Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
08:05am, Tuesday, Aug 12, 2025
Zenas BioPharma, Inc. (NASDAQ: ZBIO) - quick read on what's happening inside
The company is executing an expensive, accelerated clinical and pre-commercial build for its lead drug obexelimab while monetizing regional rights (Zai, Tenacia, BMS). Cash and liquid securities are healthy today, but bu...
08:04am, Tuesday, Aug 12, 2025
TScan Therapeutics, Inc. (NYSE: TCRX) - Quick read on what's happening inside
Short summary: the company is stepping up R&D and converting collaboration activity (Amgen) into recognitions of revenue while continuing to burn cash. Management says current resources fund operations into Q1 2027, but...
08:03am, Tuesday, Aug 12, 2025
Sable Offshore Corp. (NYSE: SOC) - Quick operational & income-statement snapshot
What's happening inside: production was restarted (May 15, 2025) and oil began flowing from six wells to onshore storage, the company raised equity in May 2025, but the restart accelerated the Senior Secured Term Lo...
08:02am, Tuesday, Aug 12, 2025
Grace Therapeutics, Inc. (NASDAQ: ACST) - Q1 (quarter ended June 30, 2025) snapshot
What's happening inside: management has pivoted to focus on the lead asset GTx‑104, completed the Phase 3 STRIVE‑ON program, submitted an NDA for GTx‑104 on June 25, 2025, and raised a material private placement i...
08:01am, Tuesday, Aug 12, 2025
Snapshot - Mereo BioPharma Group plc (NASDAQ: MREO)
What's happening inside: the company is advancing late‑stage rare‑disease programs (setrusumab and alvelestat), progressing Phase 3 activity with partner Ultragenyx, converting debt to equity to reduce interest burden, and recognizing a small li...
07:03am, Tuesday, Aug 12, 2025
DarioHealth Corp. (NASDAQ: DRIO) - Q2 2025 executive snapshot
What's happening: management is cutting operating costs and integrating acquisitions while leaning on a new Callodine credit facility ($32.5M drawn at close) to fund growth. Gross margins improved, but the company remains unprofitable,...
07:02am, Tuesday, Aug 12, 2025
Snapshot - Liquidia Corporation (NASDAQ: LQDA)
What's happening inside: FDA approved YUTREPIA on May 23, 2025 and Liquidia commercially launched it on June 2, 2025. The company has moved from R&D focus into commercialization (hiring, inventory build, sales shipments) and drew additional funding u...
07:01am, Tuesday, Aug 12, 2025
NeurAxis, Inc. (NASDAQ: NRXS) - Q2 2025 quick read
Key points & statistics
* Net sales Q2 2025: $894,086 (up 46.2% YoY from $611,500).
* Net sales six months 2025: $1,789,741 (up 42.3% YoY).
* Gross profit Q2 2025: $747,443; gross margin Q2 2025: 83.6% (down from 88.0% in Q2 2024).
* Cost of good...
07:01am, Tuesday, Aug 12, 2025
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) - quick reality check
Milestone is a clinical-stage cardio‑pharma company focused on etripamil (CARDAMYST). Management received a March 2025 CRL (CMC/manufacturing nitrosamine questions), submitted a response that the FDA accepted, and the agency set ...
06:21pm, Monday, Aug 11, 2025
Monroe Capital Corporation (NASDAQ: MRCC) - Quick read on "what's happening inside"
Snapshot / what changed in Q2 2025
* Total investments (fair value): $367,700,000 (down from $457,048,000 at 12/31/24).
* Total assets: $394,617,000; Total liabilities: $215,025,000; Net assets: $179,592,000.
* Ne...
06:19pm, Monday, Aug 11, 2025
Synchronoss Technologies, Inc. (NASDAQ: SNCR) - concise operational and income-statement brief from the Form 10‑Q for the quarter ended June 30, 2025.
Quick take
* Company is a white‑label cloud/software provider (Synchronoss Personal Cloud) with most revenue subscription‑based and heavily teleco...
06:19pm, Monday, Aug 11, 2025
Humacyte, Inc. (NASDAQ: AHAC) - Quick read on what's happening inside
Snapshot / what changed this quarter
- FDA approval and U.S. commercial launch of Symvess; first commercial shipments began March 2025.
- Revenue has started but remains very small: product and contract sales only began in 2025...
06:18pm, Monday, Aug 11, 2025
Snapshot - GSR III Acquisition Corp. (NASDAQ: GSRTU)
What's happening inside: the company is a blank‑check (SPAC) vehicle that completed an IPO, holds roughly $236.3 million in a trust account earning interest, has signed a Business Combination Agreement with Terra Innovatum (April 21, 2025), and...
06:17pm, Monday, Aug 11, 2025
SmartFinancial Q2: Loan, deposit growth drives higher NII/NIM and profits; provisions, expenses rise
SmartFinancial, Inc. (NASDAQ: SMBK) - Quick internal read
What's happening inside
SmartFinancial is growing loans and deposits aggressively year‑to‑date, translating higher loan yields into materially higher net interest income and improved margins. Profitability is up (quarter and YTD) while cre...
06:16pm, Monday, Aug 11, 2025
GrowGeneration Corp. (OTCBB: GRWG) - Q2 2025 snapshot
Inside the company: management completed a major restructuring (store closures, cost cuts), closed/ consolidated underperforming locations, acquired Viagrow (June 6, 2025), and is remediating a material internal-control weakness in its MMI (St...
